All Stories

  1. A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia

    Article • Journal of the Endocrine Society, February 2017, Endocrine Society

    Dr JEROME GUECHOT, Antonin Lamaziere

  2. Estrogen resistance

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2016, Endocrine Society

    Dr JEROME GUECHOT, DR SAKIAN KHERRA

  3. Apports de la LC-MS/MS pour le diagnostic et le suivi des hyperplasies congénitales des surrénales

    Article • Annales d Endocrinologie, September 2016, Elsevier

    Dr JEROME GUECHOT

  4. Human Liver Fibrogenesis: The Proof of Concept of HCV-, Ethanol- or Palmitate-Induced Liver Fibrosis in the Ex Vivo Model of Human Liver Slices Culture

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr JEROME GUECHOT

  5. Non-invasive evaluation of liver fibrosis: More well-validated tests available for patient management

    Article • Liver International, May 2015, Wiley

    Dr JEROME GUECHOT

  6. An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr JEROME GUECHOT, Thierry Poynard

  7. P0675 : An ex vivo model of human liver slices culture for evaluating liver fibrogenesis

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr JEROME GUECHOT

  8. 316 Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy

    Article • European Urology Supplements, April 2015, Elsevier

    Dr JEROME GUECHOT

  9. Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Dr JEROME GUECHOT, Thierry Poynard

  10. Comparaison des performances diagnostiques du Prostate Health Index (PHI) et du Prostate Cancer Antigen 3 (PCA-3) pour le dépistage du cancer de la prostate

    Article • Progrès en Urologie, November 2014, Elsevier

    Dr JEROME GUECHOT

  11. Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy

    Article • The Prostate, October 2014, Wiley

    Dr JEROME GUECHOT

  12. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations

    Article • Clinics and Research in Hepatology and Gastroenterology, November 2013, Elsevier

    Dr JEROME GUECHOT

  13. Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

    Article • Annals of Internal Medicine, September 2013, American College of Physicians

    Dr JEROME GUECHOT

  14. Contribution of the ELFG Test in Algorithms of Non-Invasive Markers towards the Diagnosis of Significant Fibrosis in Chronic Hepatitis C

    Article • PLoS ONE, March 2013, PLOS

    Dr JEROME GUECHOT

  15. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy

    Article • Clinica Chimica Acta, January 2013, Elsevier

    Dr JEROME GUECHOT

  16. Comparative determinations of non SHBG-bound serum testosterone, using ammonium sulfate precipitation, Concanavalin A binding or calculation in men

    Article • Steroids, October 2012, Elsevier

    Dr JEROME GUECHOT

  17. 1079 THE ELF SCORE IMPROVES THE PERFORMANCE OF THE 4 MORE VALIDATED TESTS FOR THE DIAGNOSIS OF SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS C (CHC)

    Article • Journal of Hepatology, April 2012, Elsevier

    Dr JEROME GUECHOT

  18. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2012, De Gruyter

    Dr JEROME GUECHOT

  19. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study

    Article • Journal of Hepatology, January 2012, Elsevier

    Dr JEROME GUECHOT

  20. Application de la spectrométrie de masse en exploration hormonale

    Article • Revue Francophone des Laboratoires, December 2011, Elsevier

    Dr JEROME GUECHOT

  21. 338 STEATO-HEPATITIS HAS A STRONG IMPACT ON LIVER STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY IN CHRONIC HEPATITIS C PATIENTS

    Article • Journal of Hepatology, March 2011, Elsevier

    Dr JEROME GUECHOT

  22. Assessment of new hyaluronic acid assays and their impact on FibroMeter scores

    Article • Clinica Chimica Acta, January 2011, Elsevier

    Dr JEROME GUECHOT

  23. Thyroid function at the third trimester of pregnancy in a Northern French population

    Article • Annales d Endocrinologie, December 2010, Elsevier

    Dr JEROME GUECHOT

  24. 1045 SERUM OSTEOPROTEGERIN, A NEW SERUM MARKER OF LIVER FIBROSIS

    Article • Journal of Hepatology, April 2010, Elsevier

    Dr JEROME GUECHOT

  25. 432 PROSPECTIVE INDEPENDENT VALIDATION AND COMPARISON OF 10 BIOMAKERS AND TRANSIENT ELASTROGRAPHY (FIBROSCAN™) FOR LIVER FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC HEPATITIS C

    Article • Journal of Hepatology, April 2010, Elsevier

    Dr JEROME GUECHOT

  26. Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration

    Article • Equine Veterinary Journal, January 2010, Wiley

    Dr JEROME GUECHOT

  27. Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort

    Article • Clinica Chimica Acta, January 2010, Elsevier

    Dr JEROME GUECHOT

  28. New reusable Celite®/ethylene glycol cartridges for selective chromatography of steroids before immunoassay

    Article • Clinical Biochemistry, November 2009, Elsevier

    Dr JEROME GUECHOT

  29. Dosage de la testostérone plasmatique : difficultés méthodologiques et intérêt physiopathologique

    Article • Revue Francophone des Laboratoires, July 2009, Elsevier

    Dr JEROME GUECHOT

  30. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients

    Article • Journal of Hepatology, June 2009, Elsevier

    Dr JEROME GUECHOT

  31. 613 THE ANTIFIBROTIC PENTOXYPHILLINE/A-TOCOPHEROL ASSOCIATION DOES NOT LIMIT LIVER FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C – ANRS HC 10

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr JEROME GUECHOT

  32. P.380 Evaluation comparative des marqueurs sériques de fibrose hépatique : intérêt dans la prise en charge des patients atteints d’une hépatite chronique à virus C

    Article • Gastroentérologie Clinique et Biologique, March 2009, Elsevier

    Dr JEROME GUECHOT

  33. Automated assay of hyaluronic acid in serum

    Article • Immuno-analyse & Biologie Spécialisée, June 2008, Elsevier

    Dr JEROME GUECHOT

  34. Simple Laboratory Test of Neuroendocrine Disturbance in Depression: 11 p.m. Saliva Cortisol

    Article • Neuropsychobiology, February 2008, Karger Publishers

    Dr JEROME GUECHOT

  35. The use of enzyme results for liver fibrosis evaluation neccessitates standardization

    Article • Hepatology, February 2008, Wiley

    Dr JEROME GUECHOT

  36. Determination of Bioavailable Testosterone [Non Sex Hormone Binding Globulin (SHBG)-Bound Testosterone] in a Population of Healthy French Men: Influence of Androstenediol on Testosterone Binding to SHBG

    Article • Clinical Chemistry, October 2007, AACC

    Dr JEROME GUECHOT

  37. Évaluation Non Invasive de la Fibrose Hépatique au Cours des Hépatites Chroniques Virales C

    Article • Revue Francophone des Laboratoires, July 2007, Elsevier

    Dr JEROME GUECHOT

  38. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C

    Article • Hepatology, January 2007, Wiley

    Dr JEROME GUECHOT

  39. Direct and indirect evidence for the reversibility of cirrhosis

    Article • Human Pathology, December 2006, Elsevier

    Dr JEROME GUECHOT

  40. CO17 - En france, la secrétion thyroïdienne est-elle insuffisante chez la femme enceinte ?

    Article • Annales d Endocrinologie, October 2006, Elsevier

    Dr JEROME GUECHOT

  41. Évaluation non invasive de la fibrose hépatique au cours des hépatites chroniques virales C

    Article • La Presse Médicale, September 2006, Elsevier

    Dr JEROME GUECHOT

  42. Estrone

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  43. Testostérone

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  44. Dihydrotestostérone

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  45. Cortisol

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  46. 11-Désoxycortisol

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  47. Acide hyaluronique

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  48. 17-Cétostéroïdes urinaires

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  49. Delta 4 androstènedione

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  50. 17-hydroxystéroïdes urinaires

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  51. 17-alpha-hydroxyprogestérone

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  52. Déhydroépiandrostérone (DHEA) et sulfate de DHEA

    Article • EMC - Biologie Médicale, January 2006, Elsevier

    Dr JEROME GUECHOT

  53. Harmonization of liver enzyme results: calibration for aminotransferases and gamma glutamyltransferase

    Article • Journal of Hepatology, September 2004, Elsevier

    Dr JEROME GUECHOT

  54. Évaluation de la fibrose hépatique

    Article • Revue Fran&c edil aise des Laboratoires, December 2003, Elsevier

    Dr JEROME GUECHOT

  55. 396 Evidence that insulin resistance is not the consequence but the cause of steatosis and fibrosis progression in patients with chronic hepatitis C

    Article • Hepatology, January 2003, Elsevier

    Dr JEROME GUECHOT

  56. Values of sperm thiobarbituric acid-reactive substance in fertile men

    Article • Clinica Chimica Acta, November 2002, Elsevier

    Dr JEROME GUECHOT

  57. Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery

    Article • Journal of Controlled Release, October 2002, Elsevier

    Dr JEROME GUECHOT

  58. Long lasting suppression of disease liver activity may lead to a reversibility of cirrhosis

    Article • Journal of Hepatology, April 2001, Elsevier

    Dr JEROME GUECHOT

  59. Hyaluronidase activity in serum of patients with monoclonal gammapathy

    Article • Clinica Chimica Acta, November 2000, Elsevier

    Dr JEROME GUECHOT

  60. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis

    Article • Journal of Hepatology, March 2000, Elsevier

    Dr JEROME GUECHOT

  61. Seminal androgen concentrations and residual sperm cytoplasm

    Article • Clinica Chimica Acta, August 1998, Elsevier

    Dr JEROME GUECHOT

  62. Dosage de la testostérone circulante en pratique clinique: intérêt des mesures de la forme libre et de la fraction biodisponible

    Article • Immuno-analyse & Biologie Spécialisée, March 1998, Elsevier

    Dr JEROME GUECHOT

  63. Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients

    Article • Journal of Hepatology, August 1997, Elsevier

    Dr JEROME GUECHOT

  64. Intérêt du dosage de la testostérone biodisponible dans les dysérections

    Article • Andrologie, June 1996, Springer Science + Business Media

    Dr JEROME GUECHOT

  65. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts

    Article • European Journal of Endocrinology, October 1995, Bioscientifica

    Dr JEROME GUECHOT

  66. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of α-interferon therapy

    Article • Journal of Hepatology, January 1995, Elsevier

    Dr JEROME GUECHOT

  67. CYTOKINE RESPONSE TO BURN INJURY

    Article • Journal of Trauma and Acute Care Surgery, May 1994, Wolters Kluwer Health

    Dr JEROME GUECHOT

  68. Predictive factors in ursodeoxycholic acid-treated patients with primary biliary Cirrhosis: Role of serum markers of connective tissue

    Article • Hepatology, March 1994, Wiley

    Dr JEROME GUECHOT

  69. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C

    Article • Journal of Hepatology, January 1994, Elsevier

    Dr JEROME GUECHOT

  70. Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease

    Article • Journal of Hepatology, January 1994, Elsevier

    Dr JEROME GUECHOT

  71. Étude de l'acide hyaluronique au cours de l'infection HIV. Intérêt du dosage dans le sarcome de Kaposi

    Article • La Revue de Médecine Interne, January 1994, Elsevier

    Dr JEROME GUECHOT

  72. Serum hyaluronan and liver fibrosis in chronic viral hepatitis C: Effect of interferon-$alpha; therapy

    Article • Hepatology, October 1993, Elsevier

    Dr JEROME GUECHOT

  73. Évaluation analytique du dosage de l'HCG avec l'automate d'immunoanalyse Vidas

    Article • Immuno-analyse & Biologie Spécialisée, October 1992, Elsevier

    Dr JEROME GUECHOT

  74. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor–α production by monocytes

    Article • Hepatology, September 1992, Wiley

    Dr JEROME GUECHOT

  75. Tumor necrosis factor-α in liver transplantation and resection

    Article • Journal of Hepatology, January 1992, Elsevier

    Dr JEROME GUECHOT

  76. Effect of Dihydrotestosterone on the Rate of Ethanol Elimination in Healthy Men

    Article • Alcoholism Clinical and Experimental Research, April 1991, Wiley

    Dr JEROME GUECHOT

  77. Quantitation of hepatic fibrosis in Chronic Hepatitis C (CHC): Support for the contribution of serum hyaluronic acid

    Article • Journal of Hepatology, January 1991, Elsevier

    Dr JEROME GUECHOT

  78. Problèmes particuliers posés par l'immunodosage des stéroïdes

    Article • Immuno-analyse & Biologie Spécialisée, September 1990, Elsevier

    Dr JEROME GUECHOT

  79. Action of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjects.

    Article • Journal of the American College of Nutrition, February 1990, Taylor & Francis

    Dr JEROME GUECHOT

  80. Ischemia-reperfusion liver injury: The role of cysteinyl-leukotrienes (LT)

    Article • Journal of Hepatology, January 1990, Elsevier

    Dr JEROME GUECHOT

  81. Testosterone and its binding in hyperthyroid women before and under antithyroid drug therapy

    Article • European Journal of Endocrinology, September 1989, Bioscientifica

    Dr JEROME GUECHOT

  82. Effect ofD-tryptophan-6-luteinizing hormone-releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma

    Article • Hepatology, September 1989, Wiley

    Dr JEROME GUECHOT

  83. Effect of Protein Binding on Testosterone Extraction by Human Cirrhotic Liver: Evidence for a Dissociation-Limited Uptake*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1989, Endocrine Society

    Dr JEROME GUECHOT

  84. Evidence of the Intact Hepatocyte Theory in Alcoholic Cirrhosis

    Article • Scandinavian Journal of Gastroenterology, January 1989, Taylor & Francis

    Dr JEROME GUECHOT

  85. Sex hormone imbalance in male alcoholic cirrhotic patients with and without hepatocellular carcinoma

    Article • Cancer, August 1988, Wiley

    Dr JEROME GUECHOT

  86. Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids

    Article • Gastroenterology, December 1987, Elsevier

    Dr JEROME GUECHOT

  87. Hepatic uptake of sex steroids in men with alcoholic cirrhosis

    Article • Gastroenterology, January 1987, Elsevier

    Dr JEROME GUECHOT

  88. Rhabdomyolysis and acute renal failure in a patient with thermal injury

    Article • Intensive Care Medicine, May 1986, Springer Science + Business Media

    Dr JEROME GUECHOT

  89. HIGH LEVEL OF βhCG IN SPERMATIC VEIN OF PATIENTS WITH SEMINOMA

    Article • The Lancet, November 1983, Elsevier

    Dr JEROME GUECHOT

  90. Physiological and Pathological Variations in Saliva Cortisol

    Article • Hormone Research, January 1982, Karger Publishers

    Dr JEROME GUECHOT